2019-11-28 10:37

New presentation from Stora Aktiedagen Stockholm on 25 Nov

CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached notification.

 

2021-04-12 08:00
Qlife publishes Annual report 2020

The report can be downloaded from the website or ordered via the company; info@Egoo.health.

2021-03-31 20:16
Correction: Notice of annual general meeting in Qlife Holding AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

2021-03-31 08:15
Notice of annual general meeting in Qlife Holding AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

2021-03-31 08:00
The Nomination Committee’s proposals for new board members in Qlife

Qlife’s Nomination Committee proposes that the Annual General Meeting elects Mette-Marie Harild, Ulrik Harrysson and Mikael Persson as new Board members.

2021-02-18 10:00
QLIFE HOLDING AB YEAR END REPORT 2020, Q4

FINANCIAL SUMMARY - FOURTH QUARTER 2020

2021-01-29 08:00
Qlife receives order from Statens Serum Institut for COVID-19 testing

“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking.

2021-01-25 08:00
Qlife granted its first patent for Egoo.Health device

The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit.

2021-01-07 08:00
Qlife CE-marks COVID-19 test

The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.

2020-12-22 10:59
Qlife raises loans of SEK 15 million to strengthen working capital ahead of the upcoming market launch.

Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.